Strategic partnerships Verb Surgical is backed by Verily and Ethicon (Johnson & Johnson), indicating strong institutional support and potential for co-development opportunities, procurement collaborations, and extended value propositions with large medical device ecosystems.

Robotics and AI focus The company targets robotic surgery, advanced visualization, instrumentation, and data analytics with a digital surgery platform, presenting opportunities to sell complementary robotics components, AI software integrations, and data-enabled workflow improvements to hospitals and health systems.

Growth potential With a small-to-mid employee base and revenue in the low millions, Verb Surgical represents a high-growth potential client for scalable solutions such as training programs, service contracts, regulatory-compliant hardware updates, and deployment-oriented support packages.

Expansion readiness Past partnerships and ongoing development of Surgery 4.0 indicate readiness for broader adoption; sales opportunities exist in installation readiness, clinical integration, and onboarding services across multi-site health networks.

Tech ecosystem fit Utilization of Salesforce, SAP, Oracle Eloqua, and cloud/collaboration tools suggests receptiveness to enterprise-grade vendor integrations, CRM-enabled sales motions, and value-selling messaging around interoperability and data analytics platforms.